Investment Analysts’ Weekly Ratings Changes for Olin (OLN)

Olin (NYSE: OLN) recently received a number of ratings updates from brokerages and research firms:

  • 1/30/2024 – Olin had its price target raised by analysts at The Goldman Sachs Group, Inc. from $55.00 to $61.00. They now have a “neutral” rating on the stock.
  • 1/29/2024 – Olin had its price target raised by analysts at Royal Bank of Canada from $58.00 to $64.00. They now have an “outperform” rating on the stock.
  • 1/29/2024 – Olin had its price target raised by analysts at Barclays PLC from $49.00 to $57.00. They now have an “equal weight” rating on the stock.
  • 1/29/2024 – Olin had its price target raised by analysts at Stifel Nicolaus from $65.00 to $66.00. They now have a “buy” rating on the stock.
  • 1/26/2024 – Olin had its price target raised by analysts at UBS Group AG from $56.00 to $58.00. They now have a “neutral” rating on the stock.
  • 1/11/2024 – Olin had its price target raised by analysts at UBS Group AG from $53.00 to $56.00. They now have a “neutral” rating on the stock.
  • 1/9/2024 – Olin had its price target raised by analysts at KeyCorp from $61.00 to $66.00. They now have an “overweight” rating on the stock.

Olin Stock Up 2.3 %

OLN stock opened at $52.46 on Tuesday. The company’s 50 day simple moving average is $52.03 and its 200-day simple moving average is $50.80. The firm has a market capitalization of $6.43 billion, a PE ratio of 14.82, a P/E/G ratio of 0.28 and a beta of 1.44. Olin Co. has a 12 month low of $41.71 and a 12 month high of $63.06. The company has a debt-to-equity ratio of 1.14, a current ratio of 1.29 and a quick ratio of 0.73.

Insider Buying and Selling

In other news, CFO Todd A. Slater sold 63,250 shares of the firm’s stock in a transaction on Tuesday, January 30th. The shares were sold at an average price of $54.15, for a total value of $3,424,987.50. Following the transaction, the chief financial officer now owns 137,517 shares of the company’s stock, valued at approximately $7,446,545.55. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other news, VP Valerie A. Peters sold 71,800 shares of the company’s stock in a transaction that occurred on Wednesday, January 31st. The shares were sold at an average price of $52.52, for a total value of $3,770,936.00. Following the completion of the sale, the vice president now directly owns 19,469 shares of the company’s stock, valued at approximately $1,022,511.88. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Todd A. Slater sold 63,250 shares of the company’s stock in a transaction that occurred on Tuesday, January 30th. The stock was sold at an average price of $54.15, for a total transaction of $3,424,987.50. Following the completion of the sale, the chief financial officer now directly owns 137,517 shares of the company’s stock, valued at $7,446,545.55. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 674,378 shares of company stock worth $36,298,062. 1.60% of the stock is owned by insiders.

Institutional Trading of Olin

Several institutional investors and hedge funds have recently added to or reduced their stakes in OLN. Vanguard Group Inc. increased its stake in Olin by 3.2% in the 1st quarter. Vanguard Group Inc. now owns 15,867,281 shares of the specialty chemicals company’s stock valued at $829,542,000 after buying an additional 493,052 shares during the period. State Street Corp boosted its holdings in Olin by 0.6% in the 1st quarter. State Street Corp now owns 5,581,714 shares of the specialty chemicals company’s stock valued at $291,812,000 after purchasing an additional 31,587 shares during the period. Hotchkis & Wiley Capital Management LLC raised its stake in shares of Olin by 0.5% in the 2nd quarter. Hotchkis & Wiley Capital Management LLC now owns 5,428,806 shares of the specialty chemicals company’s stock valued at $278,986,000 after buying an additional 29,180 shares in the last quarter. Boston Partners increased its position in shares of Olin by 122.8% during the 4th quarter. Boston Partners now owns 5,029,377 shares of the specialty chemicals company’s stock worth $271,152,000 after purchasing an additional 2,772,274 shares in the last quarter. Finally, Yacktman Asset Management LP acquired a new stake in shares of Olin during the 2nd quarter worth about $221,775,000. 85.69% of the stock is owned by institutional investors and hedge funds.

Olin Corporation manufactures and distributes chemical products in the United States, Europe, Asia Pacific, Latin America, and Canada. It operates through three segments: Chlor Alkali Products and Vinyls; Epoxy; and Winchester. The Chlor Alkali Products and Vinyls segment offers chlorine and caustic soda, ethylene dichloride and vinyl chloride monomers, methyl chloride, methylene chloride, chloroform, carbon tetrachloride, perchloroethylene, hydrochloric acid, hydrogen, bleach products, potassium hydroxide, and chlorinated organics intermediates and solvents.

Read More

Receive News & Ratings for Olin Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olin Co and related companies with MarketBeat.com's FREE daily email newsletter.